Clinical Trial Update: Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating a chemotherapy-free induction regimen for Philadelphia chromosome-positive acute lymphoblastic leukemia using inotuzumab ozogamicin i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Besponsa (inotuzumab ozogamicin)

Snippet

Sponsor: University of Chicago | Conditions: Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Status: SUSPENDED